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Abstract
Introduction: Alcohol consumption may promote aromatization of androgens to estrogens, which may partly
explain the observations linking alcohol consumption to higher breast cancer risk. Whether alcohol consumption is
associated with endogenous estrogen levels, and mammographic density phenotypes in premenopausal women
remains unclear.
Methods: Alcohol consumption was collected by self-report and interview, using semi quantitative food frequency
questionnaires, and a food diary during seven days of a menstrual cycle among 202 premenopausal women,
participating in the Energy Balance and Breast Cancer Aspects (EBBA) study I. Estrogen was assessed in serum and
daily in saliva across an entire menstrual cycle. Computer-assisted mammographic density (Madena) was obtained
from digitized mammograms taken between days 7–12 of the menstrual cycle. Multivariable regression models
were used to investigate the associations between alcohol consumption, endogenous estrogen and mammographic
density phenotypes.
Results: Current alcohol consumption was positively associated with endogenous estrogen, and absolute
mammographic density. We observed 18 % higher mean salivary 17β-estradiol levels throughout the menstrual
cycle, among women who consumed more than 10 g of alcohol per day compared to women who consumed
less than 10 g of alcohol per day (p = 0.034). Long-term and past-year alcohol consumption was positively
associated with mammographic density. We observed a positive association between alcohol consumption
(past year) and absolute mammographic density; high alcohol consumers (≥7 drinks/week) had a mean
absolute mammographic density of 46.17 cm2 (95 % confidence interval (CI) 39.39, 52.95), while low alcohol
consumers (<1 drink/week) had a mean absolute mammographic density of 31.26 cm2 (95 % CI 25.89, 36.64)
(p-trend 0.001). After adjustments, high consumers of alcohol (≥7 drinks/week), had 5.08 (95 % CI 1.82, 14.20) times
higher odds of having absolute mammographic density above median (>32.4 cm2), compared to low (<1 drink/week)
alcohol consumers.
Conclusion: Alcohol consumption was positively associated with daily endogenous estrogen levels and
mammographic density in premenopausal women. These associations could point to an important area of
breast cancer prevention.
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Introduction
High alcohol consumption has consistently been associ-
ated with breast cancer development [1–5], while a
positive association between alcohol consumption and
mammographic density, a strong independent biomarker
for breast cancer development [6], has been observed in
some studies [7–9], but not all [10]. In addition, few
studies have included current and long-term alcohol
consumption when studying the association between al-
cohol consumption and breast cancer risk [11]. Thus,
whether there is an association between alcohol con-
sumption and mammographic density phenotypes among
premenopausal women remains unclear [12–14].
A positive association between endogenous estrogen
and breast cancer development has consistently been ob-
served [15, 16]. Interestingly, alcohol consumption may
interfere with estrogen pathways, by influencing both
aromatase activity, and therefore estrogen concentra-
tions, and estrogen receptors [17–19]. Moreover, alcohol
consumption may also interfere with the menstrual cycle
by reducing variability and decreasing frequency of long
cycles [20, 21]. Recently, high alcohol consumption was
associated with endogenous luteal estrogen levels [22],
and elevated weekend consumption of alcohol has been
associated with higher peak levels of estrogens [3, 23].
Thus, one of the possible hypotheses suggested to ex-
plain the role of alcohol in breast cancer development is
through its effect on the cumulative level of endogenous
estrogen throughout life.
Importantly, assessment of endogenous sex steroid
hormones among premenopausal women is complicated
by intercyclic and intracyclic variations [24], but inter-
cyclic variations seem to be less marked in nonseasonal
and industrial populations [25]. Thus, given the substan-
tial intracycle amplitude in hormone levels, at least 7–8
days/cycle should be measured but one cycle seems to
be a valid measurement in regularly cycling women in a
westernized society [24, 25]. Only a few studies have ob-
served the association between endogenous estrogens
levels and current and long-term alcohol consump-
tion using both food diary and food frequency ques-
tionnaires (FFQ) in premenopausal women, and
much remains unclear [22, 26]. Moreover, the associ-
ation between alcohol consumption in combination
with daily cyclic endogenous hormones and mammo-
graphic density phenotypes among premenopausal
women remains unclear.
Recently, we observed a positive association between
daily sex steroid hormones, growth factors, and mam-
mographic density phenotypes [27, 28], while we
previously have observed endogenous estrogen to be as-
sociated with important breast cancer risk factors in-
cluding age at menarche and body composition [29–31].
These observations support the hypothesis that several
lifestyle-related breast cancer risk factors might exert
their effect on breast cancer development through sex
steroid hormones.
On the basis of biological mechanisms suggested, and
given that alcohol intake is a modifiable lifestyle factor
and much remains unclear regarding the association be-
tween alcohol intake, endogenous estrogen, and mam-
mographic density, there is a need for additional studies.
The main aim of the present study was thus to examine
the association between current, past-year, and long-
term alcohol consumption, endogenous estrogen levels,
and mammographic density phenotypes among premen-
opausal women.
Methods
Subjects and study design
A total of 204 women, aged 25–35 years, participated
in the Norwegian Energy Balance and Breast Cancer
Aspects I (EBBA-I) study during 2000–2002 at the
Department of Clinical Research, University Hospital
of North Norway (UNN), Tromsø [29]. Women were
recruited from the general population by announcements
in local newspapers and in public meeting places. Study
subjects had to meet the following criteria, which were
checked both in a telephone interview and in a personal
interview by the same trained nurse during the entire
study period: self-reported regular menstruation (cycle
length: 22–38 days within the previous 3 months),
no use of steroid contraceptives, pregnancy or lacta-
tion in the previous 6 months, no infertility, no history
of gynecological disorders, and no chronic disorders
(e.g. diabetes, hypothyroidism/hyperthyroidism) [29].
All women were fasting when attending three subsequent
study visits throughout one menstrual cycle starting on
the first day of menstrual bleeding: first visit, days 1–5 of
the menstrual cycle (early follicular phase); second visit,
days 7–12 (late follicular phase); and third visit, days 21–
25 (late luteal phase). Two women were excluded owing
to missing mammographic data, resulting in 202 women
being included in the present study.
Clinical examination and lifestyle factors
The participants underwent clinical examination at three
scheduled visits by the same physicians. First attendance
was on the first possible day after onset of menstrual
bleeding at the Clinical Research Center, UNN, Tromsø,
Norway. Height was measured to the nearest 0.5 cm,
and weight to the nearest 0.1 kg on an electronic scale,
body mass index (BMI) was calculated (in kg/m2), and
waist circumference was measured [29]. Validated ques-
tionnaires (self-administered and interviewer administered)
were used to collect information about reproductive
history, previous hormone use, diet, and lifestyle fac-
tors [29, 31].
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Assessment of alcohol consumption
Alcohol consumption was assessed using a validated pre-
coded food diary (Department of Nutrition, University
of Oslo, Norway) and semi-quantitative FFQ. The food
diary captured current alcohol consumption during
seven selected days, representing each day of 1 week
during the menstrual cycle (days 3–6 of the follicular
phase and days 21–23 of the luteal phase) [32]. The
semi-quantitative FFQ captured long-term alcohol con-
sumption across the lifespan and alcohol consumption
during the past year: “Have you ever drunk alcohol
(yes/no)? If yes, how many glasses of wine, ½ liters
of beer, fortified wine (0.4 dl) or measures of spirits
did you drink on average per month at the following
ages? (15–19 years, 20–24 years, 25–34 years).” “Are
you currently an abstainer (yes/no)? If no, how many
measures of alcohol have you consumed on average
per month or per week in the past 12 months?” Both
assessment methods were obtained by self-report,
and were later checked for inconsistencies and miss-
ing values by trained interviewers.
Assessment of estrogen
Overnight fasting serum concentrations of estrogen were
assessed in fresh serum samples, taken at the three visits.
The serum concentration of 17β-estradiol was measured
using a direct immunometric assay (Immuno-1; Bayer
Diagnostics UNN, Tromsø, Norway), and analyzed
(Department of Clinical Chemistry, UNN, Tromsø,
Norway). The sensitivity for estradiol was 0.01 nmol/l
and the coefficient of variation (CV) was 3.9 %.
The participants collected daily morning saliva sam-
ples throughout one menstrual cycle, starting the first
day of menstrual bleeding [33]. Collection of saliva in
plastic tubes, pretreated with sodium azide, was done
according to previously established validated protocols
developed at the Reproductive Ecology Laboratory at
Harvard University, Cambridge, MA, USA and the man-
ufacturer’s protocol (Diagnostic Systems Laboratory,
Webster, TX, USA) [33, 34]. The 17β-estradiol concen-
trations were measured in daily saliva samples using a
125I-based radioimmunoassay kit (#39100; Diagnostic
Systems Laboratory, Webster, TX, USA). The samples were
stored at −70 °C. All samples were run in duplicate, and
samples from the same cycles were run within the same
assay. The assays were carried out in different batches.
All cycles were aligned to the day of ovulation based
on the identification of the drop in17β-estradiol, which
provides a reasonable estimate of the day of ovulation
[33, 35]. The mid-cycle 17β-estradiol drop could not be
made for 14 of the participants: eight participants had
too many missing days mid cycle, making it impossible
to determine a drop day; and six participants had no dis-
cernible rise or drop in estradiol during the critical time
window, and thus their cycles were unable to be aligned.
These 14 women were therefore excluded from further
analysis. The overall mean salivary 17β-estradiol concen-
tration was calculated for all 204 women, whereas mid-
menstrual 17β-estradiol (days −7 to +6) indices were
calculated for the 190 women with aligned cycles. The
sensitivity of the 17β-estradiol assay was 4 pmol/l, and
average intra-assay variability was 9 %. The measure-
ments of 17β-estradiol had higher CVs at the start and
end of the menstrual cycle, and the interassay variability
ranged from 23 % (low pool) to 13 % (high pool). Fur-
thermore, there were higher rates of missing data at the
end of the cycle, and thus we included 17β-estradiol sal-
ivary aligned measurements from day −7 to day +6 in
this study.
Assessment of mammographic density phenotypes
Bilateral two-view mammograms were obtained in the
study from all women between cycle days 7 and 12 at the
Centre of Breast Imaging, UNN, Tromsø, Norway using a
standard protocol [36]. The left craniocaudal mammo-
grams were digitized, and imported into a computerized
mammographic density assessment program (Madena;
University of Southern California School of Medicine, Los
Angeles, CA, USA) [37]. One trained reader conducted
the density measurements. The total breast area was de-
fined using a special outlining tool, and the Madena soft-
ware estimated size (in cm2) of this area. In order to assess
density, the reader outlined a region of interest (ROI), and
applied a tinting tool to pixels considered to represent
dense areas of the mammograms within the ROI. The
Madena software calculated the size of this dense area (in
cm2). Absolute mammographic breast density represented
this dense area, and percent mammographic density was
the ratio of absolute mammographic breast density to
total breast area. The mammograms were read in four
batches, with an equal number of mammograms in each
batch. A duplicate reading of 26 randomly selected mam-
mograms from two of the batches showed an intraclass
correlation coefficient for reliability of 0.94.
Statistical analysis
Based on plausible suggested mechanisms linking alcohol
to endogenous estrogen and to mammographic density,
we studied the association between current and past alco-
hol intake alone, and in combination with endogenous es-
trogen levels and the study outcomes—percent and
absolute mammographic density—using multivariate re-
gression models. Previous observations in premenopausal
[38] and postmenopausal [39] women have observed a
twofold to threefold increase in breast cancer risk for
women with percent mammographic density above 25 %.
These observations support the comparison of women
with above versus below median percent mammographic
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density. Mammographic density outcome variables were
thus used as both continuous and dichotomized variables,
representing lower and higher density using median values
as cutoff points: percent mammographic density (28.5 %),
and absolute mammographic density (32.4 cm2).
All variables, except alcohol consumption, were ap-
proximately normally distributed, allowing data analysis
by parametric tests. Alcohol consumption was somewhat
skewed and log transformation was performed prior to
linear regression analysis; thus, the log transformation
did not influence our results and the results are pre-
sented on the original scale. In addition, we log-
transformed the hormone data owing to outliers; the
results, however, were not influenced and the results are
presented on the original scale.
Descriptive characteristics are presented as mean
(standard deviation) or percent (number). Equality be-
tween categories of alcohol consumption was tested
using one-way analysis of variance for continuous vari-
ables, and the chi-square test for binary variables. Based
on suggested biological mechanisms influencing mam-
mographic density, regression models including several
potentially confounding variables were fitted. We tested
whether adjustments for potentially confounding factors
such as age (continuous), BMI (continuous), age at menar-
che (continuous), number of children (continuous), previ-
ous oral contraceptive (OR) use (categorical), current
smoking habits (categorical), energy intake (continuous),
and leisure-time activity (continuous) influenced our
estimates. Age (continuous), BMI (continuous), num-
ber of children (continuous), current smoking habits
(categorical), and previous OC use (categorical) were
included as covariates in the final models. In regression
models, alcohol consumption was considered both as a
continuous variable and as a categorical variable, and the
p-trend value was calculated based on continuous vari-
ables. Long-term alcohol consumption was defined as the
average consumption from age 15 to present, and divided
into categories: never/rarely, 1–4 drinks/month, and >1
drinks/week. Glasses of alcoholic beverages (past year
and current) reported in both the FFQ and the food diary
was converted into grams of alcohol by applying defini-
tions of standard drinks for each beverage. Past year alco-
hol consumption was then divided into categories: total
alcohol consumption (<1 drinks/week, 1–6 drinks/
week, ≥7 drinks/week), and beer/wine/spirits con-
sumption in past year (<1 drinks/week, ≥1 drink/week).
Current alcohol consumption was defined as average
consumption over 7 days and was divided in two categor-
ies: <1 drink/day and ≥1 drink/day. We defined one alco-
holic drink as 10 g alcohol, which corresponds to about a
small bottle (330 ml) of beer with 3.2 g alcohol per 100 ml,
one glass (125 ml) of wine with 8.8 g alcohol per 100 ml,
or a small glass (23 ml) of spirits with 31.7 g per 100 ml.
In the logistic regression models, alcohol consumption
during the past year was used as a categorical variable,
and the median split of mammographic density pheno-
types was used as the dependent variable. One model
was adjusted for age, and a multivariable model was fur-
ther adjusted for BMI, number of children, current
smoking habits, and previous OC use.
Multivariable adjusted, linear, mixed models for re-
peated measures were used to examine variation in daily
salivary 17β-estradiol across the menstrual cycle, accord-
ing to low (<1 drink/day) and high (≥1 drink/day) levels
of current alcohol consumption. In addition, we strati-
fied the analyses by median split of absolute mammo-
graphic density (32.4 cm2). The Toeplitz covariance
structure was used in all models.
All statistical tests were two-sided using a significance
level of p <0.05. Statistical analyses were conducted
with SPSS version 21.0 (IBM Corporation, Armonk,
NY, USA).
Ethical consideration
All of the participating women signed an informed con-
sent form, including taking a mammogram. The study
protocol was reviewed and approved by the Regional
Committee for Medical Research Ethics Northern Norway
and the Norwegian Data Inspectorate (reference: 2001/
3676 8 and 11).
Results
Characteristics of the study population are presented in
Table 1. Women who were high alcohol consumers (≥7
drinks/week, past year) tended to be younger, of older
age at menarche, and had fewer children compared with
low alcohol consumers (<1 drink/week, past year). Alco-
hol consumption in the past year was positively associ-
ated with both percent mammographic density and
absolute mammographic density (Table 1). There was a
moderate positive correlation between current and past-
year alcohol consumption (Additional file 1).
After adjustments, we observed an association be-
tween alcohol consumption in the past year and absolute
mammographic density. High alcohol consumers (≥7
drinks/week) over the past year had a 47.6 % higher
mean absolute mammographic density compared with
low alcohol consumers (<1 drinks/week) over the past
year (46.2 cm2 (95 % CI 39.4, 53.0) vs. 31.3 cm2 (95 % CI
25.9, 36.6) (p-trend 0.001)). The same positive associ-
ation was observed with long-term alcohol use and abso-
lute mammographic density (p-trend = 0.029) (Table 2).
In multivariable linear regression analyses, we calcu-
lated estimated change in mammographic density per
unit increase in the alcohol intake variable. Alcohol
consumption in the past year was associated with both
percent mammographic density (β-value 0.7, 95 % CI
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0.2, 1.2) and absolute mammographic density (β-value
1.3, 95 % CI 0.5, 2.0). Similar associations were appar-
ent, when past-year alcohol consumption was analyzed
by alcohol type; for example, wine, beer, and others
(Table 3). No association was observed between total
current alcohol consumption and percent or absolute
mammographic density (Table 3).
In age-adjusted logistic regression analyses, women
with high alcohol consumption (≥7 drinks/week) had 2.4
(95 % CI 1.0, 5.6) and 4.4 (95 % CI 1.8, 10.9) higher odds
of having high (above median) percent and absolute
mammographic density, compared with women who
were low (<1 drink/week) alcohol consumers. Similarly,
in multivariable models we observed, among high
Table 1 Characteristics of the study population by alcohol consumption (drinks/week) in the past year (FFQ), Norwegian EBBA-I
study (n = 202)a
Variable Overall (n = 202)a Low consumers
(<1 drink/week) (n = 66)a
Moderate consumers
(1–6 drinks/week) (n = 96)a
High consumers
(≥7 drinks/week) (n = 40)a
p valueb
Characteristics
Age (years) 30.7 (3.07) 31.17 (2.86) 30.75 (3.16) 29.87 (3.09) 0.105
Education (years) 16.1 (3.02) 15.82 (2.85) 15.98 (3.04) 16.70 (3.20) 0.324
Reproductive history
Age at menarche (years) 13.1 (1.36) 12.75 (1.29) 13.21 (1.36) 13.48 (1.36) 0.016
Cycle length (days) 28.2 (3.17) 28.40 (4.13) 28.01 (2.78) 28.98 (3.5) 0.314
Parous (%) 51.2 61.2 46.0 27.5 0.002
Number of children (n) 0.91 (1.13) 1.30 (1.29) 0.80 (0.98) 0.53 (0.99) 0.001
Anthropometric measuresc
BMI (kg/m2) 24.4 (3.77) 24.47 (2.30) 24.55 (3.56) 23.92 (3.35) 0.665
Waist (cm) 79.5 (9.80) 76.69 (11.26) 80.28 (9.56) 77.44 (7.47) 0.300
Lifestyle factors
Leisure time (MET/hour/week) 57.6 (88.6) 48.09 (33.44) 63.23 (121.18) 59.59 (45.16) 0.552
Oral contraceptive use
Previous use (%) 82.7 76.1 85.0 90.0 0.119
Sum use (years) 3.7 (3.7) 3.27 (3.72) 3.99 (3.69) 3.84 (3.63) 0.458
Alcohol consumption in the past year
Alcohol (drinks/week) 3.46 (4.10) 0.24 (0.28) 2.67 (1.46) 10.84 (2.87) <0.001
Abstainers (%) 6.8
Smoking habits
Current smokers (%) 22.1 11.9 25.0 32.5 0.030
Former smokers (%) 45.4 32.8 50.0 55.0 0.037
Serum hormonesd
Estradiol (pmol/l) 146.7 (61.6) 145.5 (70.49) 147.4 (62.80) 146.8 (41.04) 0.983
Salivary hormones
Estradiol, overall averagee (pmol/l) 17.9 (8.79) 17.68 (7.65) 17.61 (9.29) 18.98 (9.40) 0.691
Estradiol, mid-menstrualf (pmol/l) 18.20 (8.98) 17.69 (7.52) 18.05 (9.69) 19.01 (9.59) 0.839
Mammogramsg
Percent mammographic density (%) 29.8 (19.0) 28.08 (19.05) 27.33 (18.02) 38.51 (19.30) 0.005
Absolute mammographic density (cm2) 34.7 (23.4) 31.57 (21.00) 31.89 (22.73) 46.77 (25.23) 0.001
Data presented as mean (standard deviation). One drink or unit is equal to 10 g alcohol
BMI body mass index, EBBA-I Norwegian Energy Balance and Breast Cancer Aspects I, FFQ food frequency questionnaire, MET metabolic equivalents
aNumbers may vary owing to missing information
bEquality between levels were tested using one-way analysis of variation for continuous variables and the chi-square test for binary variables
cMeasurements at days 1–5 after onset of menstrual cycle
dSerum samples in early follicular phase: days 1–5 after onset of menstrual cycle
eDaily saliva samples throughout an entire menstrual cycle
fDaily saliva samples mid menstrual cycle, aligned cycle days −7 to 6
gMammograms were taken days 7–12 (mid-cycle phase)
Frydenberg et al. Breast Cancer Research  (2015) 17:103 Page 5 of 12
consumers of alcohol, 5.1 (95 % CI 1.8, 14.2) times
higher odds of having absolute mammographic density
above median compared with low consumers. When we
examined the type of alcohol consumed, high consumers
(≥2 drinks/week) of wine had statistically significant 2.5
times higher odds ratio of having absolute mammo-
graphic density above the median, compared with low
consumers (<2 drinks/week) of wine. However, our sam-
ple size was limited regarding the type of beverages
(Table 4).
We found that women who consumed more than one
unit of alcohol per day had 18 % higher mean salivary
17β-estradiol levels across the menstrual cycle compared
with women who consumed less than one unit of alco-
hol per day (p = 0.034) (Fig. 1a). In analyses stratified by
median absolute mammographic density, we observed
that women with high current alcohol consumption (>1
drink/day) and high absolute mammographic density
(>32.4 cm2) had 28 % higher mean salivary 17β-estradiol
levels throughout the menstrual cycle, compared with
women who consumed less than one unit of alcohol per
day (p = 0.033) (Fig. 1c). No association was observed
between current alcohol consumption and salivary 17β-
estradiol in women with low absolute mammographic
density (≤32.4 cm2) (Fig. 1b). Moreover, no associations
were observed between alcohol consumption, salivary
estrogen, and percent mammographic density. Of note,
no associations were observed between alcohol con-
sumption, serum estrogen, and mammographic density
phenotypes (data not shown). To test for interaction be-
tween alcohol consumption and mammographic density,
variables were first dichotomized and then entered into
the linear mixed model with interaction terms. We ob-
served no statistically significant interactions between
alcohol consumption and mammographic density (data
not shown).
Discussion
In this study among premenopausal women, we ob-
served positive associations between current alcohol
consumption and endogenous estrogen levels, as women
who reported consuming >10 g alcohol per day during
the last week had 18 % higher mean 17β-estradiol level
throughout the menstrual cycle compared with women
who consumed <10 g alcohol per day during the last
week. We also observed positive associations between
past-year and long-term alcohol intake and percent and
absolute mammographic density. Women who reported
drinking ≥7 drinks/week over the past year had 48 %
higher absolute mammographic density, compared with
low alcohol consumers (<1 drinks/week). Similarly, high
alcohol consumers in the past year had five times higher
odds ratio of having above-median absolute mammo-
graphic density compared with low alcohol consumers
during the past year. Of note, the current average alco-
hol consumption in our study was low, with a mean al-
cohol consumption of 2.9 drinks per week, and 18 %
reported drinking more than one drink of alcohol per
day (mean 6.7 g alcohol/day). Of note, the women re-
ported drinking on average 11.3 g alcohol at weekends
and on average 2.5 g alcohol per day on weekdays, which
corresponds with levels of alcohol consumption ob-
served in comparable populations [10]. Furthermore,
we observed similar alcohol consumption by the two
assessment methods used (semi-quantitative FFQ and
food diary).
Owing to the limited number of participants included,
and the limited variation in type of alcoholic beverage,
we could not study whether a specific type of beverage
influenced hormonal levels and mammographic density
more than others. However, the confounders did not
differ by type of beverage.
Our study is the first, to our knowledge, to study
associations between current and long-term alcohol
consumption and endogenous cyclic premenopausal es-
trogen levels and mammographic density phenotypes.
Studies consistently support a modest association be-
tween alcohol consumption and breast cancer risk [1–5],
Table 2 Multivariable adjusted means of mammographic density
measures by alcohol consumption by long-term, past-year, and
current consumption in premenopausal women (n = 202)a
Alcohol consumptionb Number Percent density (%) Absolute density (cm2)
Long-term, averagec
Never/rarely 7 32.14 (21.44, 42.84) 36.66 (20.17, 53.15)
1–4 drinks/month 134 26.74 (24.30, 29.17) 31.02 (27.27, 34.77)
>1 drinks/week 43 33.67 (29.27, 38.11) 42.08 (35.27, 48.89)
p-linear trend 0.051 0.029
Past year, averaged
<1 drinks/week 66 28.71 (25.23, 32.20) 31.26 (25.89, 36.64)
1–6 drinks/week 95 27.52 (24.73, 30.31) 32.17 (27.87, 36.48)
≥7 drinks/week 40 36.42 (32.02, 40.83) 46.17 (39.39, 52.95)
p-linear trend 0.003 0.001
Current, past weeke
<1 drink/day 143 28.11 (25.79, 30.42) 33.08 (29.46, 36.69)
≥1 drink/day 58 33.57 (29.87, 37.28) 40.38 (32.78, 44.35)
p-difference 0.016 0.121
Data presented as mean (95 % confidence interval). All analyses have used
multivariate linear models
FFQ food frequency questionnaire
Adjusted for age (continuous), body mass index (continuous), number of
children (continuous), previous oral contraceptives (categorical), and current
smokers (categorical)
aNumbers may vary owing to missing information
bOne drink or unit is equal to 10 g alcohol
cAlcohol consumption reported from age 15 to present time, FFQ
dAlcohol consumption reported in past year, FFQ
eAlcohol consumption reported in last 7 days representing 1 week, food diary
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Table 3 Association between alcohol consumption by type of alcohol and mammographic density phenotypes in premenopausal
women (n = 202)a using multivariable linear regression models
Alcohol consumption Percent densityb (%) p-value Absolute densityb (cm2) p-value
Past yearc
Total alcohol (drinks/weekd) 0.72 (0.23, 1.22) 0.004 1.28 (0.52, 2.03) 0.001
Beer (drinks/weekd) 0.94 (0.15, 1.74) 0.021 1.87 (0.65, 3.09) 0.003
Wine (drinks/weekd) 2.02 (0.62, 3.41) 0.005 2.84 (0.66, 5.01) 0.011
Otherse (drinks/weekd) 1.74 (−0.23, 3.70) 0.084 3.17 (0.13, 6.21) 0.041
Current, past weekf
Total alcohol (g/day) 0.11 (−0.12, 0.34) 0.362 0.26 (−0.19, 0.61) 0.153
Beer (g/day) 1.71 (0.19, 3.22) 0.027 3.24 (0.91, 5.57) 0.007
Wine (g/day) 1.23 (−0.30, 2.75) 0.113 1.90 (−0.46, 4.25) 0.114
Otherse (g/day) −0.15 (−1.93, 1.62) 0.865 −0.50 (−3.25, 2.26) 0.723
Data presented as β-value (95 % confidence interval). All analyses have used multivariable linear regression models, and are adjusted for age (continuous), body
mass index (continuous), number of children (continuous), previous oral contraceptives (categorical), and current smokers (categorical)
FFQ food frequency questionnaire
aNumbers may vary owing to missing information
bEstimated change in mammographic density per unit increase in the alcohol intake variable
cAlcohol consumption reported in past year, FFQ
dOne drink or unit is equal to 10 g alcohol
eIncludes spirits and fortified wine
fAlcohol consumption reported in last 7 days representing 1 week, food diary
Table 4 Above-median percent (>28.5 %) and absolute (>32.4 cm2) mammographic density according to past-year alcohol consumption
by type in premenopausal women (n = 202)a
Alcohol consumption, past yearb Age-adjusted modelc Multivariable-adjusted modeld
Number Percent density (%) Absolute density (cm2) Percent density (%) Absolute density (cm2)
Total
<1 drink/week 66 1.00 1.00 1.00 1.00
1–6 drinks/week 96 0.90 (0.47, 1.72) 1.10 (0.57, 2.11) 0.92 (0.39, 2.15) 1.16 (0.56, 2.42)
≥7 drinks/week 40 2.37 (1.00, 5.60) 4.38 (1.76, 10.87) 2.78 (0.90. 8.60) 5.08 (1.82, 14.20)
p-trend 0.094 0.004 0.106 0.004
Beer
<2 drinks/week 156 1.00 1.00 1.00 1.00
≥2 drinks/week 45 1.33 (0.66, 2.67) 1.96 (0.97, 3.98) 1.25 (0.51, 3.03) 1.95 (0.90, 4.24)
p-difference 0.423 0.062 0.627 0.092
Wine
<2 drinks/week 169 1.00 1.00 1.00 1.00
≥2 drinks/week 33 2.18 (0.97, 4.93) 2.60 (1.14, 5.93) 2.06 (0.77, 5.53) 2.47 (1.03, 5.92)
p-difference 0.060 0.024 0.152 0.043
Otherse
<2 drinks/week 184 1.00 1.00 1.00 1.00
≥2 drinks/week 18 2.80 (0.85, 9.17) 2.86 (0.88, 9.35) 2.55 (0.67, 9.64) 2.65 (0.79, 9.04)
p-difference 0.090 0.081 0.196 0.119
Data presented as odds ratio (95 % confidence interval). All analyses used multivariable logistic regression models
FFQ food frequency questionnaire
aNumbers may vary owing to missing information
bAlcohol consumption reported in past year, FFQ. One drink or unit is equal to 10 g alcohol
cAdjusted for age (continuous)
dAdjusted for age (continuous), body mass index (continuous), number of children (continuous), previous oral contraceptives (categorical), and current
smokers (categorical)
eIncludes spirits and fortified wine
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with a suggestive dose–response relationship [1]. One of
the possible hypotheses suggested to explain the role of
alcohol in breast cancer development is through alcohol’s
effect on the cumulative level of estrogen throughout life.
However, inconsistent associations have been observed
between alcohol and timed sampling of estrogens in the
Fig. 1 Adjusted mean salivary estrogen by high (red line) and low (blue line) current alcohol intake a–c stratified by absolute mammographic
density b, c among 190 premenopausal women. a Current alcohol intake: <1 alcohol drink/day, 17.55 pmol/l; ≥1 alcohol drink/day, 20.70 pmol/l;
p = 0.034. b Absolute mammographic density ≤2.4 cm2: <1 alcohol drink/day, 17.67 pmol/l; ≥ 1 alcohol drink/day, 19.09 pmol/l; p = 0.486. c Absolute
mammographic density >32.4 cm2: ≤1 alcohol drink/day, 17.53 pmol/l; >1 alcohol drink/day, 22.36 pmol/l; p = 0.033. All analyses used linear mixed
models for repeated measures, adjusted for age (continuous), body mass index (kg/m2, continuous), number of children (continuous), previous oral
contraceptives (categorical), and current smokers (categorical). One drink or unit is equal to 10 g alcohol. Mean salivary estradiol throughout
menstrual cycle
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menstrual cycle [22]. Recently, a positive association be-
tween alcohol and luteal estrogen, but not between follicu-
lar estrogens, was observed [22]. These observations
underline that additional studies are warranted to better
understand the associations between alcohol and the cu-
mulative level of estrogen throughout the menstrual cycle
phase during premenopausal years. Alcohol consumption
may act through increased aromatase activity [18],
but other different biological mechanisms have been hy-
pothesized [40, 41], supporting an association between
endogenous estrogen and alcohol consumption. Interest-
ingly, an association between endogenous estrogen and
mammographic density has been observed [42–44]. The
observed effect of high alcohol consumption on mammo-
graphic density may thus be explained by a direct effect of
alcohol on breast density and/or an indirect effect through
the estrogen pathway.
Previous studies report inconsistent results regarding
the association between alcohol consumption during
the past year and mammographic density phenotypes
[7, 8, 10, 12, 45]. Few studies have examined the as-
sociation between alcohol consumption and mammo-
graphic density in premenopausal women [12–14].
However, in some studies including both premenopausal
and postmenopausal women, a positive association be-
tween alcohol consumption and qualitatively [7, 12] and
quantitatively [13, 14] determined mammographic dens-
ity was observed. Alcohol consumption over the past year
reflects the cumulative alcohol consumption during
12 months, while current alcohol consumption assessed
by our food diary reflects alcohol consumption during
1 week. The association observed in the present study be-
tween past-year alcohol consumption and mammo-
graphic density may thus be easier to observe compared
with current alcohol consumption.
Interestingly, almost all of our observed associations
were in relation to absolute mammographic density, also
observed by others [45, 46]. Absolute mammographic
density reflects dense areas of the breast, mainly com-
posed of epithelial and stromal tissues, while percent
mammographic density reflects relative amounts of
fibroglandular and fat tissue [42, 47, 48]. Importantly,
the absolute dense area is considered to represent the
actual target tissue for tumor development, as ductal
carcinoma in situ and invasive breast cancer more often
occur in dense areas [49–51].
To our knowledge, our study—in contrast to others
[46]—includes long-term, past-year, and current alcohol
consumption by type of alcohol and total consumption
during 7 days of one menstrual cycle, in relation to
mammographic density phenotypes. Our study thus
combines several unique features because alcohol con-
sumption was assessed among premenopausal women
both by self-report combined with a supplementary
interview using validated semi-quantitative FFQ [52] as
well as a food diary [32].
Estrogen was assessed in both serum and saliva
throughout an entire menstrual cycle, following strict
procedures and validated methods [33]. This is the rec-
ommended approach, yet it is rarely achieved owing to
its logistic complexity [24]. However, serum estradiol
includes both the protein-bound fraction and the free
fraction of the hormone, while salivary estradiol reflects
free, biologically active estradiol levels [29]. Of note, we
observed no correlations between serum and salivary
hormones among the participants in total, which is con-
sistent with the results of other studies [53], as a correl-
ation between salivary and serum concentrations within
the individual was observed but not in total. This may
be explained by the fact that serum hormones is
dependent on the binding protein capacity, which differs
greatly among individuals. Moreover, the serum levels in
one individual, assessed only on a few days during a
menstrual cycle, cannot be predicted from salivary con-
centrations in others [33, 53]. Exploratory non-invasive
sampling of salivary hormones may thus provide novel
insight into the associations between bioactive hor-
mones, alcohol, and mammographic density in breast
cancer research [53]. Of importance, the curves and sal-
ivary estrogen concentrations describing ovarian func-
tion in the presented EBBA-I study resemble those
observed in other populations [35, 54].
Mammograms were obtained for study purposes justi-
fied by evaluation in ethical committees, during the late
follicular phase (days 7–12 after first day of bleeding),
avoiding possible variations in mammographic density
during the menstrual cycle [55]. Thus, owing to safety
concerns, we could only obtain one measure of mammo-
graphic density, and therefore could not measure density
pattern changes over a menstrual cycle. The validated
computer-assisted method used was read by one experi-
enced blinded reader, and has previously been shown to
give a superior prediction of breast cancer risk com-
pared with qualitative methods [37, 56].
The present hypothesis-generating study also has some
limitations. The small sample size limits further stratified
analyses. However, our multiple salivary hormone vari-
ables are not considered to be independent measures,
but indices within the same aligned menstrual cycle.
Multiple corrections with Bonferroni for each variable
would thus be too stringent. The assessment of daily sal-
ivary levels of unbound bioavailable estradiol throughout
a menstrual cycle is unique, but there is a need for fur-
ther studies because total serum hormones and free un-
bound salivary hormone levels are often correlated
within individuals, while pooled data often show no sig-
nificant correlations [33, 53]. Immunoassay methods
used in the present study have most often been replaced
Frydenberg et al. Breast Cancer Research  (2015) 17:103 Page 9 of 12
recently by liquid chromatography–mass spectrometry,
which compared with the immunoassay method is a
more efficient way of analyzing salivary hormones with
higher specificity and sensitivity. However, previous
studies on estradiol measurements, specifically, have
shown a high correlation between mass spectrometry
and immunoassays [57]. The present study lasted for
one menstrual cycle, and thus we were not able to cap-
ture any changes in estrogen levels between cycles. Alco-
hol consumption as assessed by a food diary was
registered for 7 days (each day of a week represented),
and captured binge versus daily consumption. The possi-
bility to study daily variation for each cycle day was thus
not possible. However, to minimize any information bias
by day of the week or by cycle day, the current alcohol
consumption was collected by a food diary for all seven
unique days.
Given the increase in alcohol consumption among
women worldwide [58], an association between alcohol
consumption and breast cancer biomarkers, including
endogenous estrogen levels and mammographic density,
may have public health impact. If the association be-
tween alcohol use and mammographic density is deter-
mined to be causal, it could provide additional impetus
for women to limit their alcohol consumption.
Conclusion
Alcohol consumption was positively associated with
mammographic density phenotypes in premenopausal
women. Higher levels of daily estrogen were observed
among women with high current alcohol consumption
and high mammographic density. Given that alcohol in-
take consistently has been observed to be associated
with higher breast cancer risk, these positive associations
observed between alcohol consumption, endogenous es-
trogen, and mammographic density could point to an
important area of breast cancer prevention. However,
the results need to be replicated in larger studies, asses-
sing information of both current and long-term alcohol
consumption.
Additional file
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